当前位置: X-MOL 学术Sci. Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets.
Scientific Reports ( IF 4.6 ) Pub Date : 2018-Apr-20 , DOI: 10.1038/s41598-018-24568-9
Yara Alenazi 1 , Kamayani Singh 1 , Graham Davies 1 , James R O Eaton 1, 2 , Philip Elders 1 , Akane Kawamura 1, 2 , Shoumo Bhattacharya 1
Affiliation  

Both CC and CXC-class chemokines drive inflammatory disease. Tick salivary chemokine-binding proteins (CKBPs), or evasins, specifically bind subsets of CC- or CXC-chemokines, and could precisely target disease-relevant chemokines. Here we have used yeast surface display to identify two tick evasins: a CC-CKBP, P1243 from Amblyomma americanum and a CXC-CKBP, P1156 from Ixodes ricinus. P1243 binds 11 CC-chemokines with Kd < 10 nM, and 10 CC-chemokines with Kd between 10 and 100 nM. P1156 binds two ELR + CXC-chemokines with Kd < 10 nM, and four ELR + CXC-chemokines with Kd between 10 and 100 nM. Both CKBPs neutralize chemokine activity with IC50 < 10 nM in cell migration assays. As both CC- and CXC-CKBP activities are desirable in a single agent, we have engineered "two-warhead" CKBPs to create single agents that bind and neutralize subsets of CC and CXC chemokines. These results show that tick evasins can be linked to create non-natural proteins that target subsets of CC and CXC chemokines. We suggest that "two-warhead" evasins, designed by matching the activities of parental evasins to CC and CXC chemokines expressed in disease, would achieve precision targeting of inflammatory disease-relevant chemokines by a single agent.

中文翻译:

基因工程双弹头evasin提供了一种精确靶向疾病相关趋化因子子集的方法。

CC 和 CXC 类趋化因子都会导致炎症性疾病。蜱唾液趋化因子结合蛋白 (CKBP) 或 evasins 特异性结合 CC 或 CXC 趋化因子子集,并且可以精确地靶向与疾病相关的趋化因子。在这里,我们使用酵母表面展示来识别两种蜱逃避素:来自美洲钝蜱的CC-CKBP,P1243和来自蓖麻硬蜱的CXC-CKBP,P1156。P1243 结合 11 个 K d  < 10 nM 的 CC 趋化因子,以及 10 个 K d介于 10 和 100 nM 之间的 CC 趋化因子。P1156 结合两种 ELR + CXC 趋化因子,K d  < 10 nM,并结合四种 ELR + CXC 趋化因子,K d在 10 至 100 nM 之间。 在细胞迁移测定中,两种 CKBP 均能中和趋化因子活性,IC 50 < 10 nM。由于 CC- 和 CXC-CKBP 活性在单一药剂中是理想的,因此我们设计了“双弹头”CKBP 来创建结合并中和 CC 和 CXC 趋化因子子集的单一药剂。这些结果表明,蜱逃避蛋白可以连接起来产生针对 CC 和 CXC 趋化因子子集的非天然蛋白质。我们认为,通过将亲代evasins的活性与疾病中表达的CC和CXC趋化因子相匹配而设计的“双弹头”evasins将通过单一药物实现炎症性疾病相关趋化因子的精确靶向。
更新日期:2018-04-20
down
wechat
bug